A phase I study of the combination of daily oral pazopanib with intravenous ifosfamide in patients with advanced solid malignancies.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Ifosfamide; Pazopanib
- Indications Solid tumours
- Focus Adverse reactions; Biomarker
- Acronyms Pazi
- 16 Nov 2015 Status changed from recruiting to completed.
- 06 Nov 2009 New trial record